Investor Ideas #Potcasts 514, #Cannabis News and #Stocks on the Move; (TSX: $FIRE.TO) (TSX: $AH.TO) (CSE: $PULL.C) (CSE: $LOVE.C) (TSXV: $N.V)
Delta, Kelowna, BC, January 8, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/010821-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2021/cannabis-potcasts/01081FIRE-AH-PULL-LOVE-N.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on
Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com "Potcast"
featuring cannabis news, stocks to watch as well as insights from thought
leaders and experts.
In
today’s podcast we will be looking at a few public company announcements.
The
Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) announced that it has made its first shipment
of medical cannabis to Australia in a private label transaction in which the
Company's medical cannabis will be sold in 10-gram containers and will be
distributed to patients across the country.
The Australian medical cannabis
market was characterized by strong year-over-year growth in 2020. According to
FreshLeaf Analytics' Australian Medicinal Cannabis Market Patient and Pricing
Analysis for Q3 2020, the Australian medical cannabis market is expected to
triple with regards to active patients and product sales measured by revenue.
The Company also completed its
fourth shipment of calendar 2020 to Israel through the Company's partnership
with Breath of Life International Ltd. ("BOL Pharma"), Israel's
largest and leading producer of medical cannabis and cannabis products. This
shipment was the largest to date of Jean Guy and Sensi Star strains, sold under
the Truverra label.
"We are pleased to be
introducing our medical cannabis to the Australian market," said Beena
Goldenberg, President and CEO of Supreme Cannabis. "Having already
completed shipments to Israel, our first sale into the Australian market is a
meaningful step toward executing on our international medical strategy of
creating additional wholesale medical partnerships in various international
jurisdictions. We are committed to supplying high-quality medical cannabis to
our partners; Australian patients will now be able to access our Jean Guy
strain, which is a tribute to the legendary variety offered by the Montreal
Compassion Club. We are impressed by the significant growth of the Australian
medical cannabis market and we look forward to opportunities to expand our
Australian partnership and help more Australian patients in 2021."
Aleafia
Health Inc. (TSX: AH) (OTC: ALEAF) announced entering into a definitive
three-year cannabis supply agreement with Apipharm Veletrgovina d.o.o. a
leading European pharmaceutical producer and distributor.
Apipharm specializes in the
distribution of active pharmaceutical ingredients of plant origin including
semi-synthetic cannabinoid isolates, along with the development of advanced
pharmaceutical formulations.
Under the terms of the agreement,
Aleafia Health will supply Apipharm with dried cannabis flower grown at its
Niagara greenhouse facility. Apipharm has also submitted an initial purchase
order to Aleafia Health, for 1,000 kg of premium dried flower. The initial
purchase order is expected to ship as early as the end of Q1 2021, dependent on
the timing of necessary import and export permits.
“It is our great pleasure that we
have entered into a partnership agreement with Aleafia which will strengthen
our market position in the development of advanced pharmaceutical
formulations,” said Dr. Matevz Pompe, CEO of Apiharm.
“We are delighted to open a new
international sales channel leveraging the well-established distribution
network and expertise of Apipharm,” said Aleafia Health CEO Geoffrey Benic.
“Building on our best results to date in the most recent quarter, we will
continue to execute on near-term international sales opportunities, fully
leveraging our world class Canadian cannabis production assets.”
Pure
Extracts Technologies Corp. (CSE: PULL)(OTC: PRXTF) announced that the Company received trading
approval from OTC Markets and is now trading on the OTC Market under the ticker
symbol PRXTF.
Pure Extracts CEO, Ben Nikolaevsky,
remarked, “Trading under the new OTC ticker symbol PRXTF and applying for DTC
eligibility is a major step forward in making it materially easier to welcome
U.S.-based investors as new shareholders. This is an important step in
amplifying our story to a wider audience and to grow our investor base.”
OTC Markets offer developing
Canadian companies the benefits of being publicly traded in the U.S. with lower
cost and complexity than a U.S. exchange listing. Streamlined market standards
enable Canadian companies to provide a strong baseline of transparency to
inform and engage U.S. investors. To be eligible, Canadian companies must be
current in their SEDAR reporting and undergo an annual verification and
management certification process. Pure Extracts shares will continue to trade
on the Canadian Securities Exchange (CSE) under the symbol PULL, as well as the
Frankfurt Stock Exchange under the symbol A2QJAJ.
Cannara
Biotech Inc. (CSE: LOVE) (OTCQB: LOVFF) announced that, through its wholly-owned
subsidiary, Cannara Biotech (Quebec) Inc., it has received approval from Health
Canada to amend its license to permit the sale of dried cannabis products to
provincially authorized distributors and retailers nationwide. As revenue
steadily grows over the next 12 months, Cannara expects rapid growth in
profitability and cashflow given its lean operating structure and production
cost advantage.
"Within our home province of
Quebec, demand for high quality Quebec-grown cannabis is strong and expanding
rapidly," said Zohar Krivorot, President and Chief Executive Officer of
Cannara. "The receipt of our sales licence from Health Canada is a
significant milestone in our journey and will enable us to continue executing
our plan to generate value for consumers and shareholders. We look forward to
getting our brand portfolio into the hands of customers across the province of
Quebec over the coming months."
Cannara indoor-grown cannabis is
produced to the highest quality standards. As a result cannabis is cultivated
from a bank of rare genetics, hang-dried, slow-cured, and hand-trimmed. The
Company plans to initially launch three product lines:
● THC-dominant: Top-shelf genetics
featuring hand-crafted cannabis with elevated THC and rich terpene profiles,
available in 3.5 gram and pre-roll formats.
● CBD-dominant: Unique genetics
containing less THC and more CBD available in 3.5 gram and pre-roll formats.
●
High-value: Quality
cannabis offered at an accessible price point in a 28 grams bulk format.
Namaste
Technologies Inc. (TSXV: N)) (OTC: NXTTF), a leading platform for cannabis
products, accessories, and education, announced the launch of its 2.0
consumer-focused recreational house brand "Roilty". Under the Roilty
brand, Namaste's wholly owned subsidiary CannMart Inc. will launch new products
such as live resin targeted to be available in February, followed by rosin,
shatter, crumble and wax in successive quarters. Trademark for Roilty is
pending approval.
Roilty:
● The
focus of the new brand Roilty is specifically focused around 2.0 products. With
the recent acquisition of CannMart Labs Inc., Namaste now has the capability to
develop high quality products that are in high demand at a lower price than
competitors. Roilty will be positioned as a high-end, accessible mainstream
brand
● CannMart
Labs facility in Ontario is completed for BHO extraction using leading
extraction technology, making it one of only a few facilities in Canada with
such capabilities
● Set to
produce in-house branded Cannabis 2.0 products for medical channel customers
available at CannMart.com and recreational customers across Canada through
sister company CannMart's network of provincial sales partners
● Cannabis
2.0 products initially planned include vape cartridges, live resin and shatter,
with capabilities to expand future product offerings to rosin, capsules,
tinctures and edibles
Phyto
1-Gram Vape Cartridges:
CannMart to launch Phyto 1-gram vape
carts, a product with high demand coupled with high margins. We anticipate a
shift in consumer demand from 0.5-gram to 1-gram vape carts.
The following SKU's will be
available in a 1-gram cartridge:
● Blueberry
● Pink
Kush
● Grapefruit
Haze
● Green
Apple
A purchase order from a province has
just been received for two of our best-selling strains, Blueberry and Pink
Kush. Grapefruit Haze and Green Apple are two new strains based on consumer
demand feedback.
"We are excited for the launch
of our in-house brand "Roilty" as we see an increasing demand for
additional 2.0 products with a strong value proposition," said Meni Morim,
CEO of Namaste. "We are working hard towards receiving our processing
licence from Health Canada and look forward to producing our in house branded
Cannabis 2.0 products, for our medical channel customers at CannMart.com and
recreational consumers across Canada through our network of provincial sales
partners. We are clearly focused on the
execution of our strategy to position Namaste as a leading cannabis company and
look forward to building on this positive momentum in 2021."
CannTrust
Holdings Inc. announced it is re-entering the Canadian
medical cannabis market today with its new medical brand estoraTM and will begin serving patients immediately.
estoraTM builds
on CannTrust's foundation of consistent, high quality products, with a focus on
providing superior patient care in every interaction, connecting patients,
health care practitioners and partners with the educational resources and
products they need to navigate each patient's unique medical cannabis journey.
"Since our inception, we have
been dedicated to providing Canadians with consistently high-quality medical
cannabis," said Greg Guyatt, Chief Executive Officer at CannTrust.
"We're delighted to be launching our new medical brand estoraTM with a portfolio of medical
cannabis products including oil drops, capsules and dried flower formats."
Many products are available for sale
immediately through the newly launched ecommerce site www.estoramedical.com.
"We believe it was imperative
to evolve our strong foundation in medical cannabis to meet the changing needs
of our patients," said Guyatt. "estora™
has patient care at its core. We consulted patients and health care
practitioners, learning more about their needs and refining our processes and
product offerings to elevate their experience with us."
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
Investors can trade
these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and
others.
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts
and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech,
water, renewable energy and more. Investor Idea’s original branded content
includes the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news column, Investor
Ideas Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis
Stock Investor Ideas – news, articles, podcasts and stock directory
No comments:
Post a Comment